Aspira Women’s Health (NASDAQ:AWH – Get Free Report) is expected to be posting its quarterly earnings results before the market opens on Thursday, March 27th. Analysts expect Aspira Women’s Health to post earnings of ($0.21) per share and revenue of $3.00 million for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.
Aspira Women’s Health Stock Performance
Shares of Aspira Women’s Health stock opened at $0.09 on Tuesday. Aspira Women’s Health has a one year low of $0.08 and a one year high of $3.75. The company has a market cap of $1.67 million, a P/E ratio of -0.08 and a beta of 1.57. The firm has a fifty day moving average of $0.28 and a two-hundred day moving average of $0.62.
Wall Street Analyst Weigh In
Separately, StockNews.com started coverage on shares of Aspira Women’s Health in a report on Sunday, January 12th. They set a “hold” rating for the company.
Aspira Women’s Health Company Profile
Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
Recommended Stories
- Five stocks we like better than Aspira Women’s Health
- What Are Trending Stocks? Trending Stocks Explained
- Super Micro Stock: $7.2M Call Options Signal Big Upside Potential
- P/E Ratio Calculation: How to Assess Stocks
- Top 3 Buy-and-Hold Stocks for 2025: Long-Term Winners to Watch
- 3 Healthcare Dividend Stocks to Buy
- D-Wave Stock: Is Quantum Blockchain the Next Big Catalyst?
Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with MarketBeat.com's FREE daily email newsletter.
